Marinus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRNS and other ETFs, options, and stocks.

About MRNS

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. 

CEO
Scott N. Braunstein
CEOScott N. Braunstein
Employees
165
Employees165
Headquarters
Radnor, Pennsylvania
HeadquartersRadnor, Pennsylvania
Founded
2003
Founded2003
Employees
165
Employees165

MRNS Key Statistics

Market cap
82.51M
Market cap82.51M
Price-Earnings ratio
-0.57
Price-Earnings ratio-0.57
Dividend yield
—
Dividend yield—
Average volume
1.75M
Average volume1.75M
High today
$1.65
High today$1.65
Low today
$1.46
Low today$1.46
Open price
$1.50
Open price$1.50
Volume
1.62M
Volume1.62M
52 Week high
$11.26
52 Week high$11.26
52 Week low
$1.11
52 Week low$1.11

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.